Indaptus Therapeutics, Inc. (INDP) Misses Q1 EPS by 14c
Tweet
Share
E-mailGet Alerts INDP Hot Sheet
Join SI Premium – FREE
Indaptus Therapeutics, Inc. (NASDAQ: INDP) reported Q1 EPS of ($0.32), $0.14 worse than the analyst estimate of ($0.18).
For earnings history and earnings-related data on Indaptus Therapeutics, Inc. (INDP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hewlett Packard Enterprise (HPE) Tops Q3 EPS by 19c; raises guidance
- Five Below (FIVE) Tops Q2 EPS by 35c, Beats on Revenue; Offers Q3 Revenue Guidance
- Karman Holdings stock falls after short-seller questions cash flow
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
